Name: Guobing Liu

Qualification: M.D., Ph.D

Country: china


Shanghai Institution of Medical Imaging;
Department of Nuclear Medicine,
Zhongshan Hospital,
Fudan University

Email: Send an Email


No. 180 in Fenglin Road,
Shanghai 200032,
P.R. China.

Research Interests:

  • Medical and molecular imaging of cardiavascular diseases;
  • Medical Diagnosis and Imaging of respiratory diseases, etc.



  1. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: Combination of 18F-FDG PET/CT and highresolution computed tomography features to predict invasive adenocarcinoma.
  2. Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer.
  3. Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy.
  4. Morphologic patterns and imaging features of intracranial hemangiopericytomas: A retrospective analysis.
  5. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: An 18F-FDG-PET/CT study.
  6. Improved sensitivity of 3.0 Tesla susceptibility-weighted imaging in detecting traumatic bleeds and its use in predicting outcomes in patients with mild traumatic brain injury.
  7. H magnetic resonance spectroscopy and diffusion weighted imaging findings of medulloblastoma in 3.0T MRI: A retrospective analysis of 17 cases.
  8. Primary pulmonary cryptococcosis: evaluation of CT characteristics in 26 immunocompetent Chinese patients.